Peter M. Edelbroek

4.1k total citations
63 papers, 3.0k citations indexed

About

Peter M. Edelbroek is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Peter M. Edelbroek has authored 63 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 27 papers in Pediatrics, Perinatology and Child Health and 17 papers in Pharmacology. Recurrent topics in Peter M. Edelbroek's work include Epilepsy research and treatment (31 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Neuroscience and Neuropharmacology Research (13 papers). Peter M. Edelbroek is often cited by papers focused on Epilepsy research and treatment (31 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Neuroscience and Neuropharmacology Research (13 papers). Peter M. Edelbroek collaborates with scholars based in Netherlands, United States and Germany. Peter M. Edelbroek's co-authors include Leo Stolk, Erwin A. van Vliet, Jan A. Gorter, Eleonora Aronica, Frederik A. de Wolff, Gerrit‐Jan de Haan, Frans G. Zitman, Sandra Redeker, Philip Spinhoven and Karin Roelofs and has published in prestigious journals such as Neurology, Biological Psychiatry and Pain.

In The Last Decade

Peter M. Edelbroek

62 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Edelbroek Netherlands 29 1.3k 1.0k 511 500 493 63 3.0k
G. Gatti Italy 34 1.6k 1.2× 1.6k 1.5× 550 1.1× 438 0.9× 499 1.0× 91 3.5k
Roberto Riva Italy 36 1.5k 1.2× 1.2k 1.2× 602 1.2× 443 0.9× 347 0.7× 143 3.7k
Paul Rolan Australia 32 892 0.7× 587 0.6× 556 1.1× 664 1.3× 411 0.8× 89 3.5k
R. Duane Sofia United States 31 937 0.7× 654 0.6× 1.4k 2.7× 866 1.7× 231 0.5× 155 3.5k
Sebastian Härtter Germany 33 1.0k 0.8× 417 0.4× 532 1.0× 844 1.7× 360 0.7× 81 3.8k
Angela K. Birnbaum United States 29 1.3k 1.0× 1.5k 1.5× 420 0.8× 394 0.8× 327 0.7× 110 2.8k
Mervyn J. Eadie Australia 38 2.0k 1.5× 2.4k 2.3× 373 0.7× 323 0.6× 342 0.7× 246 4.6k
Shun Higuchi Japan 38 582 0.4× 1.6k 1.6× 203 0.4× 532 1.1× 2.1k 4.3× 173 5.2k
Suneel Gupta United States 31 895 0.7× 683 0.7× 328 0.6× 277 0.6× 312 0.6× 120 3.4k
James C. Cloyd United States 36 3.5k 2.7× 3.4k 3.2× 1.1k 2.2× 500 1.0× 521 1.1× 164 5.5k

Countries citing papers authored by Peter M. Edelbroek

Since Specialization
Citations

This map shows the geographic impact of Peter M. Edelbroek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Edelbroek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Edelbroek more than expected).

Fields of papers citing papers by Peter M. Edelbroek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Edelbroek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Edelbroek. The network helps show where Peter M. Edelbroek may publish in the future.

Co-authorship network of co-authors of Peter M. Edelbroek

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Edelbroek. A scholar is included among the top collaborators of Peter M. Edelbroek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Edelbroek. Peter M. Edelbroek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertram, Edward H. & Peter M. Edelbroek. (2021). Chronic limbic epilepsy models for therapy discovery: Protocols to improve efficiency. Epilepsia. 62(9). 2252–2262. 1 indexed citations
2.
Holtman, Linda, Erwin A. van Vliet, Peter M. Edelbroek, Eleonora Aronica, & Jan A. Gorter. (2010). Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Research. 91(1). 49–56. 74 indexed citations
3.
Wegner, Ilse, Peter M. Edelbroek, Gerrit‐Jan de Haan, Dick Lindhout, & Josemir W. Sander. (2010). Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia. 51(12). 2500–2502. 36 indexed citations
4.
Haan, Gerrit‐Jan de, et al.. (2009). A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 51(3). 478–482. 75 indexed citations
5.
Bakvis, Patricia, Philip Spinhoven, Erik J. Giltay, et al.. (2009). Basal hypercortisolism and trauma in patients with psychogenic nonepileptic seizures. Epilepsia. 51(5). 752–759. 104 indexed citations
6.
Edelbroek, Peter M., et al.. (2009). Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls. Therapeutic Drug Monitoring. 31(3). 327–336. 424 indexed citations
7.
Vliet, Erwin A. van, et al.. (2008). Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia. 49(7). 1151–1159. 37 indexed citations
8.
Vliet, Erwin A. van, Peter M. Edelbroek, Rob A. Voskuyl, et al.. (2007). Region-Specific Overexpression of P-glycoprotein at the Blood-Brain Barrier Affects Brain Uptake of Phenytoin in Epileptic Rats. Journal of Pharmacology and Experimental Therapeutics. 322(1). 141–147. 96 indexed citations
9.
Hoogtanders, K., J. van der Heijden, M. Christiaans, et al.. (2006). Therapeutic drug monitoring of tacrolimus with the dried blood spot method. Journal of Pharmaceutical and Biomedical Analysis. 44(3). 658–664. 154 indexed citations
10.
Vliet, Erwin A. van, Peter M. Edelbroek, Sandra Redeker, et al.. (2006). Inhibition of the Multidrug Transporter P‐Glycoprotein Improves Seizure Control in Phenytoin‐treated Chronic Epileptic Rats. Epilepsia. 47(4). 672–680. 153 indexed citations
11.
Vliet, Erwin A. van, Sandra Redeker, Eleonora Aronica, Peter M. Edelbroek, & Jan A. Gorter. (2005). Expression of Multidrug Transporters MRP1, MRP2, and BCRP Shortly after Status Epilepticus, during the Latent Period, and in Chronic Epileptic Rats. Epilepsia. 46(10). 1569–1580. 99 indexed citations
13.
Hardus, P., et al.. (2001). Visual Field Loss Associated with Vigabatrin: Quantification and Relation to Dosage. Epilepsia. 42(2). 262–267. 69 indexed citations
14.
16.
Brouwer, O.F., Peter M. Edelbroek, T. Stijnen, et al.. (1992). Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances. Epilepsy Research. 13(3). 245–253. 22 indexed citations
17.
Zitman, Frans G., et al.. (1991). Low Dose Amitriptyline in Chronic Pain. Survey of Anesthesiology. XXXV(6). 349–349. 1 indexed citations
18.
Zitman, Frans G., et al.. (1990). Low dose amitriptyline in chronic pain: The gain is modest. Pain. 42(1). 35–42. 47 indexed citations
19.
Edelbroek, Peter M., et al.. (1986). Analgesic and antidepressive effects of low-dose amitriptyline in relation to its metabolism in patients with chronic pain. Clinical Pharmacology & Therapeutics. 39(2). 156–162. 20 indexed citations
20.
Edelbroek, Peter M., et al.. (1984). Amitriptyline metabolism in relation to antidepressive effect. Clinical Pharmacology & Therapeutics. 35(4). 467–473. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026